UPB
Upstream Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.01
−1.15%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 177.28x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.21x
- Price / sales
- 104.23x
- Price / cash flow
- -2.41x
Enterprise value
- Enterprise value
- $68.8M
- EV / sales
- 21.79x
- EV / EBITDA
- -0.44x
- EV / EBIT
- -0.40x
- Market cap
- $329.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026